These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18182323)

  • 1. Resistance is futile: antineuronal autoimmunity in multiple sclerosis.
    Huizinga R; Linington C; Amor S
    Trends Immunol; 2008 Feb; 29(2):54-60. PubMed ID: 18182323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis.
    Zamvil SS; Steinman L
    Neuron; 2003 Jun; 38(5):685-8. PubMed ID: 12797954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal loss in multiple sclerosis: causes and mechanisms.
    Criste G; Trapp B; Dutta R
    Handb Clin Neurol; 2014; 122():101-13. PubMed ID: 24507515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex interaction between mutant HNRNPA1 and gE of varicella zoster virus in pathogenesis of multiple sclerosis.
    Kattimani Y; Veerappa AM
    Autoimmunity; 2018 Jun; 51(4):147-151. PubMed ID: 29996671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets of the humoral autoimmune response in multiple sclerosis.
    Fraussen J; Claes N; de Bock L; Somers V
    Autoimmun Rev; 2014 Nov; 13(11):1126-37. PubMed ID: 25108168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
    Bitsch A; Schuchardt J; Bunkowski S; Kuhlmann T; Brück W
    Brain; 2000 Jun; 123 ( Pt 6)():1174-83. PubMed ID: 10825356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological aspects of axon injury in multiple sclerosis.
    Howe CL
    Curr Top Microbiol Immunol; 2008; 318():93-131. PubMed ID: 18219816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo models of multiple sclerosis.
    van der Star BJ; Vogel DY; Kipp M; Puentes F; Baker D; Amor S
    CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):570-88. PubMed ID: 22583443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN; Snyder DS
    CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demyelination in multiple sclerosis.
    Lubetzki C; Stankoff B
    Handb Clin Neurol; 2014; 122():89-99. PubMed ID: 24507514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
    Genain CP; Cannella B; Hauser SL; Raine CS
    Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss.
    Sobottka B; Harrer MD; Ziegler U; Fischer K; Wiendl H; Hünig T; Becher B; Goebels N
    Am J Pathol; 2009 Sep; 175(3):1160-6. PubMed ID: 19700745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
    Blauth K; Soltys J; Matschulat A; Reiter CR; Ritchie A; Baird NL; Bennett JL; Owens GP
    Acta Neuropathol; 2015 Dec; 130(6):765-81. PubMed ID: 26511623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.
    Zhou D; Srivastava R; Nessler S; Grummel V; Sommer N; Brück W; Hartung HP; Stadelmann C; Hemmer B
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19057-62. PubMed ID: 17142321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of multiple sclerosis.
    Kipp M; van der Valk P; Amor S
    CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):506-17. PubMed ID: 22583433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofascin as a novel target for autoantibody-mediated axonal injury.
    Mathey EK; Derfuss T; Storch MK; Williams KR; Hales K; Woolley DR; Al-Hayani A; Davies SN; Rasband MN; Olsson T; Moldenhauer A; Velhin S; Hohlfeld R; Meinl E; Linington C
    J Exp Med; 2007 Oct; 204(10):2363-72. PubMed ID: 17846150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptic axonal antigens and axonal loss in multiple sclerosis.
    DeVries GH
    Neurochem Res; 2004 Nov; 29(11):1999-2006. PubMed ID: 15662834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis: an immune or neurodegenerative disorder?
    Trapp BD; Nave KA
    Annu Rev Neurosci; 2008; 31():247-69. PubMed ID: 18558855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications.
    Simkins TJ; Duncan GJ; Bourdette D
    Curr Neurol Neurosci Rep; 2021 Apr; 21(6):26. PubMed ID: 33835275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.